The Economic Times daily newspaper is available online now.

    Russia's CoviVac more than 80% effective against COVID-19: Ifax

    Synopsis

    Russia's third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine's developer as saying on Wednesday.

    covivacReuters
    Russia's third vaccine against COVID-19, CoviVac, is more than 80% effective according to preliminary data, the Interfax news agency cited the vaccine's developer as saying on Wednesday.

    The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year, Interfax added.


    (You can now subscribe to our Economic Times WhatsApp channel)

    (Catch all the Business News, Breaking News, Budget 2024 Events and Latest News Updates on The Economic Times.)

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)

    (Catch all the Business News, Breaking News, Budget 2024 Events and Latest News Updates on The Economic Times.)

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more
    The Economic Times

    Stories you might be interested in